Cookies help us improve your ABPI online experience. If you accept their use, continue using our site. or, find out more about cookies.
International Policy Manager (Trade)
We are seeking an exceptional person to lead in the development and implementation of the ABPI’s trade policy agenda.
Apply now. Closing date 17 December 2021.
Invest and innovate to keep UK life sciences globally competitive
Richard Torbett outlines the case for investing in our sector ahead of the autumn's Comprehensive Spending Review.
ABPI publishes third annual report on UK clinical research
The ABPI's report calls for lessons from COVID-19 to be used to revitalise the post-pandemic clinical research environment.
ABPI 2021 Code of Practice
The ABPI Code of Practice sets out the requirements the industry must comply with and supports companies’ commitment to self-regulation and to operate in a professional, ethical and transparent manner.
ABPI & AAC ATMP Roadmap launch webinar | 9 Dec 2021
We are delighted to invite you to the launch of the brand new Accelerated Access Collaborative/ABPI Advanced Therapeutic Medicinal Products (ATMP) Roadmap.
Online Workshop on SMC: How to prepare and submit to SMC | 13-14 Dec 2021
Making high quality, evidence-based submissions to SMC can mean the difference between successful or very limited access to NHS Scotland for medicines.
We represent our members, using their insight and experience to tell the story of how they change the lives of millions of people every day.
Clinical trials are important for patients, they are beneficial to the NHS and they are good for the UK economy.
Manufacturing and quality
The UK biopharmaceutical industry has a long and proud record of high quality, reliable manufacturing of medicinal products The UK medicines industry is one of our leading manufacturing sectors, with exports worth £24 billion and generating a trade surplus of £4.9 billion in 2012.
This is the science of developing new tools, standards and approaches to evaluate the efficacy, safety, quality and performance of medical products in order to assess benefit-risk and facilitate a sound and transparent regulatory decision-making.
Drug safety - pharmacovigilance
Drug safety (also known as pharmacovigilance), is the science of detection, assessment, understanding and prevention of side effects which allows us to understand more about the risks and benefits of a medicine.